Forte Biosciences Inc (FBRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -69,375 | -35,478 | -31,476 | -13,879 | -21,708 |
| Depreciation Amortization | -173 | -119 | 9 | N/A | 36 |
| Accounts payable and accrued liabilities | 5,543 | 3,021 | 271 | 207 | -294 |
| Other Working Capital | 12,408 | 1,757 | -392 | 1,679 | 720 |
| Other Operating Activity | 715 | 74 | 2,882 | 3,808 | 4,569 |
| Operating Cash Flow | $-50,882 | $-30,745 | $-28,706 | $-8,185 | $-16,677 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 36,350 | -35,956 | 135 | N/A | N/A |
| PPE Investments | -116 | -37 | -88 | N/A | N/A |
| Investing Cash Flow | $36,234 | $-35,993 | $47 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 76,831 | 53,014 | 25,016 | 7,241 | 62 |
| Other Financing Activity | -7,470 | -1,157 | -332 | 0 | -106 |
| Financing Cash Flow | $69,361 | $51,857 | $24,684 | $7,241 | $-44 |
| Beginning Cash Position | 22,244 | 37,125 | 41,100 | 42,044 | 58,765 |
| End Cash Position | 76,957 | 22,244 | 37,125 | 41,100 | 42,044 |
| Net Cash Flow | $54,713 | $-14,881 | $-3,975 | $-944 | $-16,721 |
| Free Cash Flow | |||||
| Operating Cash Flow | -50,882 | -30,745 | -28,706 | -8,185 | -16,677 |
| Capital Expenditure | -116 | -37 | -88 | N/A | N/A |
| Free Cash Flow | -50,998 | -30,782 | -28,794 | -8,185 | -16,677 |